Clinical Research Directory
Browse clinical research sites, groups, and studies.
Predicting the Risk of Failure in Patients Undergoing Radiation Therapy for Localized Prostate Cancer
Sponsor: University of California, San Francisco
Summary
RATIONALE: Gathering information about the Gleason score, prostate-specific antigen (PSA) level, and cancer stage from patients who have undergone radiation therapy for prostate cancer may help doctors predict how patients respond to treatment and help plan the best treatment. PURPOSE: This clinical trial is studying the Gleason score, PSA level, and cancer stage in predicting outcome in patients who have undergone radiation therapy for localized prostate cancer.
Official title: Pre-Operative Gleason Score and PSA and Clinical Stage in Predicting the Risk of Failure in Patients Undergoing Radiation Therapy for Localized Prostate Cancer
Key Details
Gender
MALE
Age Range
18 Years - 120 Years
Study Type
OBSERVATIONAL
Enrollment
3561
Start Date
1993-02-25
Completion Date
2026-01-31
Last Updated
2025-03-20
Healthy Volunteers
No
Conditions
Interventions
medical chart review
questionnaire administration
quality-of-life assessment
brachytherapy
radiation therapy
Locations (1)
University of California, San Francisco
San Francisco, California, United States